FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2967506567> ?p ?o ?g. }

• W2967506567 endingPage "753.e15" @default.
• W2967506567 startingPage "744" @default.
• W2967506567 abstract "•Odds of having greater triglycerides increase across worsening kidney disease. •The higher triglyceride mortality risk declines across worsening kidney disease. •Results are similar in diabetics and nondiabetics and the elderly and nonelderly. Background In the general population, elevated triglyceride (TG) levels are an important risk factor for cardiovascular disease and mortality. However, in chronic kidney disease, the association of serum TGs with mortality is less clear. Objective We sought to examine the association of TGs with mortality across chronic kidney disease (CKD) stages in a large cohort of U.S. veterans. Methods We examined 2,086,904 U.S. veterans with a TG measurement obtained between a baseline period of October 2004 and September 2006, with follow-up until December 2014 (median [interquartile range {IQR}]: 9.2 [6.5, 9.9] years). Associations of TGs with all-cause and cardiovascular mortality across CKD stages were evaluated using Cox proportional hazard models. Results Patients were 64 ± 14 years old with a median (IQR) baseline TG of 129 [88, 193] mg/dL and estimated glomerular filtration rate of 76 [61, 91] mL/min/1.73 m2. More advanced CKD was associated with higher odds of TGs ≥ 240 mg/dL. Low levels of TGs < 80 mg/dL were associated with a higher risk of mortality across all stages, whereas TG levels ≥ 240 mg/dL were only associated with a higher risk of all-cause mortality in non-CKD and CKD stages 3A, 3B, and 4 (reference: TG 120 to <160 mg/dL). The relationship of higher TGs with mortality incrementally attenuated across worsening stages of CKD and attenuated to the null among patients with CKD stage 5/end-stage renal disease. Similar results were observed for cardiovascular mortality, in strata by age and diabetes, and further adjustment for high-density lipoprotein and low-density lipoprotein. Conclusion Associations of elevated TGs with all-cause and cardiovascular mortality were incrementally attenuated across more advanced stages of CKD. In the general population, elevated triglyceride (TG) levels are an important risk factor for cardiovascular disease and mortality. However, in chronic kidney disease, the association of serum TGs with mortality is less clear. We sought to examine the association of TGs with mortality across chronic kidney disease (CKD) stages in a large cohort of U.S. veterans. We examined 2,086,904 U.S. veterans with a TG measurement obtained between a baseline period of October 2004 and September 2006, with follow-up until December 2014 (median [interquartile range {IQR}]: 9.2 [6.5, 9.9] years). Associations of TGs with all-cause and cardiovascular mortality across CKD stages were evaluated using Cox proportional hazard models. Patients were 64 ± 14 years old with a median (IQR) baseline TG of 129 [88, 193] mg/dL and estimated glomerular filtration rate of 76 [61, 91] mL/min/1.73 m2. More advanced CKD was associated with higher odds of TGs ≥ 240 mg/dL. Low levels of TGs < 80 mg/dL were associated with a higher risk of mortality across all stages, whereas TG levels ≥ 240 mg/dL were only associated with a higher risk of all-cause mortality in non-CKD and CKD stages 3A, 3B, and 4 (reference: TG 120 to <160 mg/dL). The relationship of higher TGs with mortality incrementally attenuated across worsening stages of CKD and attenuated to the null among patients with CKD stage 5/end-stage renal disease. Similar results were observed for cardiovascular mortality, in strata by age and diabetes, and further adjustment for high-density lipoprotein and low-density lipoprotein. Associations of elevated TGs with all-cause and cardiovascular mortality were incrementally attenuated across more advanced stages of CKD." @default.
• W2967506567 created "2019-08-22" @default.
• W2967506567 creator A5032905509 @default.
• W2967506567 creator A5047313234 @default.
• W2967506567 creator A5074587712 @default.
• W2967506567 creator A5084375517 @default.
• W2967506567 creator A5087074877 @default.
• W2967506567 creator A5088002863 @default.
• W2967506567 date "2019-09-01" @default.
• W2967506567 modified "2023-10-14" @default.
• W2967506567 title "Serum triglycerides and mortality risk across stages of chronic kidney disease in 2 million U.S. veterans" @default.
• W2967506567 cites W1528290166 @default.
• W2967506567 cites W180481652 @default.
• W2967506567 cites W1809056726 @default.
• W2967506567 cites W1972458772 @default.
• W2967506567 cites W1980611267 @default.
• W2967506567 cites W1990737871 @default.
• W2967506567 cites W1991432513 @default.
• W2967506567 cites W2005238318 @default.
• W2967506567 cites W2033324846 @default.
• W2967506567 cites W2035227308 @default.
• W2967506567 cites W2049713354 @default.
• W2967506567 cites W2051515991 @default.
• W2967506567 cites W2066523471 @default.
• W2967506567 cites W2076284927 @default.
• W2967506567 cites W2081604608 @default.
• W2967506567 cites W2097806199 @default.
• W2967506567 cites W2101729820 @default.
• W2967506567 cites W2101864445 @default.
• W2967506567 cites W2101967622 @default.
• W2967506567 cites W2102410807 @default.
• W2967506567 cites W2108947052 @default.
• W2967506567 cites W2116404316 @default.
• W2967506567 cites W2126063322 @default.
• W2967506567 cites W2134774529 @default.
• W2967506567 cites W2145632027 @default.
• W2967506567 cites W2149433053 @default.
• W2967506567 cites W2150703986 @default.
• W2967506567 cites W2155965977 @default.
• W2967506567 cites W2159738130 @default.
• W2967506567 cites W2165692718 @default.
• W2967506567 cites W2168700908 @default.
• W2967506567 cites W2169201903 @default.
• W2967506567 cites W2293346090 @default.
• W2967506567 cites W2408002420 @default.
• W2967506567 cites W2528627149 @default.
• W2967506567 cites W2588068372 @default.
• W2967506567 cites W2594868320 @default.
• W2967506567 cites W2598498016 @default.
• W2967506567 cites W2803173125 @default.
• W2967506567 cites W2899669642 @default.
• W2967506567 doi "https://doi.org/10.1016/j.jacl.2019.08.001" @default.
• W2967506567 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31562050" @default.
• W2967506567 hasPublicationYear "2019" @default.
• W2967506567 type Work @default.
• W2967506567 sameAs 2967506567 @default.
• W2967506567 citedByCount "18" @default.
• W2967506567 countsByYear W29675065672020 @default.
• W2967506567 countsByYear W29675065672021 @default.
• W2967506567 countsByYear W29675065672022 @default.
• W2967506567 countsByYear W29675065672023 @default.
• W2967506567 crossrefType "journal-article" @default.
• W2967506567 hasAuthorship W2967506567A5032905509 @default.
• W2967506567 hasAuthorship W2967506567A5047313234 @default.
• W2967506567 hasAuthorship W2967506567A5074587712 @default.
• W2967506567 hasAuthorship W2967506567A5084375517 @default.
• W2967506567 hasAuthorship W2967506567A5087074877 @default.
• W2967506567 hasAuthorship W2967506567A5088002863 @default.
• W2967506567 hasBestOaLocation W29675065672 @default.
• W2967506567 hasConcept C119060515 @default.
• W2967506567 hasConcept C126322002 @default.
• W2967506567 hasConcept C156957248 @default.
• W2967506567 hasConcept C159641895 @default.
• W2967506567 hasConcept C207103383 @default.
• W2967506567 hasConcept C2778653478 @default.
• W2967506567 hasConcept C2908647359 @default.
• W2967506567 hasConcept C44249647 @default.
• W2967506567 hasConcept C50382708 @default.
• W2967506567 hasConcept C50440223 @default.
• W2967506567 hasConcept C71924100 @default.
• W2967506567 hasConcept C90924648 @default.
• W2967506567 hasConcept C99454951 @default.
• W2967506567 hasConceptScore W2967506567C119060515 @default.
• W2967506567 hasConceptScore W2967506567C126322002 @default.
• W2967506567 hasConceptScore W2967506567C156957248 @default.
• W2967506567 hasConceptScore W2967506567C159641895 @default.
• W2967506567 hasConceptScore W2967506567C207103383 @default.
• W2967506567 hasConceptScore W2967506567C2778653478 @default.
• W2967506567 hasConceptScore W2967506567C2908647359 @default.
• W2967506567 hasConceptScore W2967506567C44249647 @default.
• W2967506567 hasConceptScore W2967506567C50382708 @default.
• W2967506567 hasConceptScore W2967506567C50440223 @default.
• W2967506567 hasConceptScore W2967506567C71924100 @default.
• W2967506567 hasConceptScore W2967506567C90924648 @default.
• W2967506567 hasConceptScore W2967506567C99454951 @default.
• W2967506567 hasFunder F4320306127 @default.
• W2967506567 hasFunder F4320309037 @default.
• W2967506567 hasFunder F4320309610 @default.

• next